Why is the US Funding a Questionable Hepatitis B Vaccine Study in Africa?
The US government is planning to spend $1. 6 million on a study in Guinea-Bissau, a country in West Africa where nearly one in five adults has hepatitis B. The study will look at whether giving the hepatitis B vaccine to newborns is safe and effective. But many researchers are calling this study une